Home/Filings/4/0000899243-22-007483
4//SEC Filing

Giffin Brett A. 4

Accession 0000899243-22-007483

CIK 0001492674other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 7:22 PM ET

Size

5.4 KB

Accession

0000899243-22-007483

Insider Transaction Report

Form 4
Period: 2022-02-20
Giffin Brett A.
Chief Commercial Officer
Transactions
  • Award

    Restricted Stock Units

    2022-02-20+200,000200,000 total
    Common Stock (200,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The restricted stock units vest in three equal annual installments commencing on February 20, 2023.

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001892921

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 7:22 PM ET
Size
5.4 KB